JG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $1K-$15K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on Oct 11, 2019.
The trade happened on Sep 20, 2019, 21 days before it was made public.
REGN has moved +148.5% since the trade date, from $295.87 to $735.20 (Oct 2, 2026 close).
- Traded
- Sep 20, 2019
- Disclosed
- Oct 11, 2019
- Filing delay
- 21 days
- Price since
- +148.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (24)
- SellMSFT$100K-$250KOct 11, 2019
- SellADBE$1K-$15KOct 11, 2019
- BuyAPD$1K-$15KOct 11, 2019
- BuyAPH$1K-$15KOct 11, 2019
- BuyBKNG$1K-$15KOct 11, 2019
- SellCOST$1K-$15KOct 11, 2019
- BuyGOOG$1K-$15KOct 11, 2019
- BuyGOOG$1K-$15KOct 11, 2019
- BuyHLI$1K-$15KOct 11, 2019
- SellILMN$1K-$15KOct 11, 2019
- SellISRG$1K-$15KOct 11, 2019
- BuyLULU$1K-$15KOct 11, 2019
- SellMA$1K-$15KOct 11, 2019
- SellMA$1K-$15KOct 11, 2019
- BuyMNST$1K-$15KOct 11, 2019
- SellPODD$1K-$15KOct 11, 2019
- SellPYPL$1K-$15KOct 11, 2019
- SellROST$1K-$15KOct 11, 2019
- BuySCHW$1K-$15KOct 11, 2019
- SellTSM$1K-$15KOct 11, 2019
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.